Feng Wang1,2, David Kopylov3, Zhongliang Zu4,5, Keiko Takahashi6, Suwan Wang6, C Chad Quarles4,5, John C Gore4,5,7, Raymond C Harris6, Takamune Takahashi6. 1. Vanderbilt University Institute of Imaging Science, Tennessee, USA. feng.wang.1@vanderbilt.edu. 2. Radiology and Radiological Sciences, Vanderbilt University, Tennessee, USA. feng.wang.1@vanderbilt.edu. 3. Drexel University College of Medicine, Pennsylvania, USA. 4. Vanderbilt University Institute of Imaging Science, Tennessee, USA. 5. Radiology and Radiological Sciences, Vanderbilt University, Tennessee, USA. 6. Division of Nephrology and Hypertension, Vanderbilt University, Tennessee, USA. 7. Biomedical Engineering, Vanderbilt University, Tennessee, USA.
Abstract
PURPOSE: Diabetic nephropathy (DN) is the leading cause of renal failure; however, current clinical tests are insufficient for assessing this disease. DN is associated with changes in renal metabolites, so we evaluated the utility of chemical exchange saturation transfer (CEST) imaging to detect changes characteristic of this disease. METHODS: Sensitivity of CEST imaging at 7 Tesla to DN was evaluated by imaging diabetic mice [db/db, db/db endothelial nitric oxide synthase (eNOS)-/-] that show different levels of nephropathy as well as by longitudinal imaging (8 to 24 weeks). Nondiabetic (db/m) mice were used as controls. RESULTS: Compared with nondiabetic mice, the CEST contrasts of hydroxyl metabolites that correspond to glucose and glycogen were significantly increased in papilla (P), inner medulla (IM), and outer medulla (OM) in db/db and db/db eNOS-/- kidneys at 16 weeks. The db/db eNOS-/- mice that showed advanced nephropathy exhibited greater CEST effects in OM and significant CEST contrasts were also observed in cortex. Longitudinally, db/db mice exhibited progressive increases in hydroxyl signals in IM+P and OM from 12 to 24 weeks and an increase was also observed in cortex at 24 weeks. CONCLUSION: CEST MRI can be used to measure changes of hydroxyl metabolites in kidney during progression of DN. Magn Reson Med 76:1531-1541, 2016.
PURPOSE:Diabetic nephropathy (DN) is the leading cause of renal failure; however, current clinical tests are insufficient for assessing this disease. DN is associated with changes in renal metabolites, so we evaluated the utility of chemical exchange saturation transfer (CEST) imaging to detect changes characteristic of this disease. METHODS: Sensitivity of CEST imaging at 7 Tesla to DN was evaluated by imaging diabeticmice [db/db, db/db endothelial nitric oxide synthase (eNOS)-/-] that show different levels of nephropathy as well as by longitudinal imaging (8 to 24 weeks). Nondiabetic (db/m) mice were used as controls. RESULTS: Compared with nondiabetic mice, the CEST contrasts of hydroxyl metabolites that correspond to glucose and glycogen were significantly increased in papilla (P), inner medulla (IM), and outer medulla (OM) in db/db and db/db eNOS-/- kidneys at 16 weeks. The db/db eNOS-/- mice that showed advanced nephropathy exhibited greater CEST effects in OM and significant CEST contrasts were also observed in cortex. Longitudinally, db/db mice exhibited progressive increases in hydroxyl signals in IM+P and OM from 12 to 24 weeks and an increase was also observed in cortex at 24 weeks. CONCLUSION: CEST MRI can be used to measure changes of hydroxyl metabolites in kidney during progression of DN. Magn Reson Med 76:1531-1541, 2016.
Authors: Henrik J Michaely; Steven Sourbron; Olaf Dietrich; Ulrike Attenberger; Maximilian F Reiser; Stefan O Schoenberg Journal: Abdom Imaging Date: 2006-12-07
Authors: Vipul R Sheth; Yuguo Li; Liu Qi Chen; Christine M Howison; Chris A Flask; Mark D Pagel Journal: Magn Reson Med Date: 2011-10-25 Impact factor: 4.668
Authors: Kannie W Y Chan; Michael T McMahon; Yoshinori Kato; Guanshu Liu; Jeff W M Bulte; Zaver M Bhujwalla; Dmitri Artemov; Peter C M van Zijl Journal: Magn Reson Med Date: 2012-10-16 Impact factor: 4.668
Authors: Sumathy Mohan; Robert L Reddick; Nicolas Musi; Diane A Horn; Bo Yan; Thomas J Prihoda; Mohan Natarajan; Sherry L Abboud-Werner Journal: Lab Invest Date: 2008-04-07 Impact factor: 5.662
Authors: Feng Wang; Keiko Takahashi; Hua Li; Zhongliang Zu; Ke Li; Junzhong Xu; Raymond C Harris; Takamune Takahashi; John C Gore Journal: Magn Reson Med Date: 2017-07-24 Impact factor: 4.668
Authors: Timothy L Kline; Marie E Edwards; Ishan Garg; Maria V Irazabal; Panagiotis Korfiatis; Peter C Harris; Bernard F King; Vicente E Torres; Sudhakar K Venkatesh; Bradley J Erickson Journal: Abdom Radiol (NY) Date: 2018-03
Authors: Timothy L Kline; Panagiotis Korfiatis; Marie E Edwards; Kyongtae T Bae; Alan Yu; Arlene B Chapman; Michal Mrug; Jared J Grantham; Douglas Landsittel; William M Bennett; Bernard F King; Peter C Harris; Vicente E Torres; Bradley J Erickson Journal: Kidney Int Date: 2017-05-20 Impact factor: 10.612
Authors: Feng Wang; Suwan Wang; Yahua Zhang; Ke Li; Raymond C Harris; John C Gore; Ming-Zhi Zhang Journal: NMR Biomed Date: 2019-07-29 Impact factor: 4.044
Authors: Feng Wang; Daniel C Colvin; Suwan Wang; Hua Li; Zhongliang Zu; Raymond C Harris; Ming-Zhi Zhang; John C Gore Journal: Magn Reson Med Date: 2020-03-06 Impact factor: 4.668